- Major factors influencing the growth of the market.
- Leading players & Growth Strategies.
- Geographic Overview.
Market growth influenced due to following factors-
- Increasing adoption of SUBs among small companies and startups.
- Reduced automation complexity.
- Ease in the cultivation of marine organisms.
- Reduced energy and water consumption and growing biologics market.
Global market size-
According to the new market research report Single use Bioreactors Market is projected to reach $3.9 billion by 2025, at a CAGR of 18.0% during the forecast period.
Leading Players & Growth Strategies -
The prominent players operating in the single-use bioreactors market are Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck Millipore (Germany).
Thermo Fisher Scientific is the second-largest player in the single-use bioreactors market. Thermo Fisher Scientific operates in the single-use bioreactors market through the life science solutions business segment. To further increase its share in the single-use bioreactors market, the company focuses on growth strategies such as acquisitions and expansion. From 2017 to 2019, the company expanded its business in the US, China, and Scotland. In 2018, Thermo Fisher Scientific acquired the Advanced Bioprocessing business from BD. This acquisition strengthened Thermo Fishers Life Sciences Solutions business segment.
For More Details, Download PDF Brochure
Geographic Overview -
North America accounted for the largest share of the single use bioreactors market, followed by Europe in 2019. The large share of the North American regional segment can be attributed to the presence of a well-established biopharmaceutical industry and major players operating in the single-use bioreactors market.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.